The US cabergoline tablets market is supported by the continued need for pharmacological management of hyperprolactinemic disorders, including conditions associated with pituitary adenomas. Cabergoline's oral administration and established role in lowering elevated prolactin levels contribute to its use in endocrinology and specialized care. The availability of generic products and established...